You searched for "assistive"
Biologics for deafness
Cochlear implants and hearing aids are inherently limited in their ability to restore ‘natural’ hearing. Biological therapy to treat inner ear pathology still is evolving rapidly with several ongoing clinical trials, though none are available for clinical practice to date....
Extranodal extension following surgical resection of HPV-positive oropharyngeal cancer – is adjuvant radiotherapy alone sufficient?
Human papillomavirus (HPV) is a known aetiological factor in oropharyngeal squamous cell carcinoma (OPSCC). HPV-positive OPSCC is recognised to have a more favourable prognosis than HPV-negative disease. Treatment deintensification for HPV+ OPSCC has therefore been an area of research focus...Lynton's Innovative Trade-In Program Promotes Sustainability and Supports NHS Decarbonisation Efforts
Laser manufacturer Lynton is thrilled to announce the Great CO2 Trade-In! A ground-breaking incentive for the ENT sector of the NHS, the Great CO2 Trade-In enables hospitals to trade in their current CO2 surgical lasers for a SmartXide Trio, regardless of the manufacturer.DP Medical brings pioneering sinus surgery wound healing gel to the UK
DP Medical Systems Ltd. has been named as the exclusive UK and Ireland supplier of Chitogel™ – a pioneering wound healing gel for use in endoscopic sinus surgery.Global Ambassadors Highlights of the Year
Audiology, Indian Subcontinent, Krishna Yerraguntla Over 466-million people live with disabling hearing loss and global costs of unaddressed hearing loss is 750-billion international dollars. Thus, to alleviate the impact of hearing loss on lives of people, The World Hearing Day...From the editor Sep/Oct 2024
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk This edition marks a milestone for me, as it is exactly 10 years since I started as editor of...
